Lochhead K M, Kharasch E D, Zager R A
Department of Medicine, University of Washington, Sealtle, USA.
Am J Pathol. 1997 Jun;150(6):2209-21.
Currently used fluorinated anesthetics are chemically related to methoxyflurane (MF), a drug that caused many cases of clinical acute renal failure during previous widespread use. To determine whether newer fluorinated anesthetics might also have nephrotoxic effects, three currently used agents (isoflurane (IF), sevoflurane (SF), and desflurane) or MF were added to rat proximal tubular segments, followed by assessments of cell integrity (ATP levels and percent lactic dehydrogenase release). Ether served as a negative control. MF, IF, and SF each induced lethal proximal tubular segment injury (up to 92, 71, and 30% lactic dehydrogenase release, respectively) and massive ATP depletion. ATP losses were observed at or near clinically relevant drug levels, they preceded lethal injury, and they correlated with approximately 50% and approximately 100% reductions in total and Na,K-ATPase-driven respiration, respectively. Clinically relevant inorganic fluoride levels simulated fluorinated anesthetic toxicity. However, fluoride release from the anesthetics (a cytochrome P450 process) did not appear to be required for toxicity (no protection with P450 inhibitors and no detectable inorganic fluoride release). As IF was judged to be one-third as toxic as MF, subclinical tubular injury (increased urine N-acetyl-beta-D-glucosaminidase (NAG) levels) after its use was sought in 19 surgical patients. Fifteen patients undergoing comparable operations with SF (approximately one-half as toxic as IF in vitro) and nine patients undergoing regional/ local anesthesia were controls. The IF group doubled its urinary NAG levels by the end of surgery (P < 0.005). Conversely, NAG levels remained stable in both control groups. The conclusions are that 1) currently used fluorinated anesthetics, particularly IF, share (but to a lesser degree) MFs tubulotoxic effects, 2) ATP depletion (probably due to decreased production) and Na,K-ATPase inhibition are likely contributing mechanisms, 3) fluoride is a prime determinant of this toxicity, and 4) tubular injury can be expressed at or near clinically relevant anesthetic/inorganic fluoride levels. That increased enzymuria can develop in patients after IF anesthesia suggests that the above in vitro data could have potential clinical relevance in selected patients.
目前使用的含氟麻醉剂在化学结构上与甲氧氟烷(MF)相关,甲氧氟烷在过去广泛使用期间导致了许多临床急性肾衰竭病例。为了确定新型含氟麻醉剂是否也具有肾毒性作用,将三种目前使用的麻醉剂(异氟烷(IF)、七氟烷(SF)和地氟烷)或MF添加到大鼠近端肾小管节段中,随后评估细胞完整性(ATP水平和乳酸脱氢酶释放百分比)。乙醚作为阴性对照。MF、IF和SF均诱导了致死性近端肾小管节段损伤(乳酸脱氢酶释放分别高达92%、71%和30%)以及大量ATP消耗。在临床相关药物浓度或接近该浓度时观察到了ATP损失,其先于致死性损伤出现,并且分别与总呼吸和钠钾ATP酶驱动的呼吸减少约50%和约100%相关。临床相关的无机氟水平模拟了含氟麻醉剂的毒性。然而,麻醉剂释放氟(一种细胞色素P450过程)似乎并非毒性所必需(细胞色素P450抑制剂无保护作用且未检测到无机氟释放)。由于IF的毒性被判定为MF的三分之一,因此在19例外科手术患者中寻找其使用后出现的亚临床肾小管损伤(尿N - 乙酰 - β - D - 氨基葡萄糖苷酶(NAG)水平升高)情况。15例接受与SF进行类似手术的患者(在体外毒性约为IF的一半)以及9例接受区域/局部麻醉的患者作为对照。IF组在手术结束时尿NAG水平翻倍(P < 0.005)。相反,两个对照组的NAG水平保持稳定。结论如下:1)目前使用的含氟麻醉剂,尤其是IF,具有(但程度较轻)MF的肾小管毒性作用;2)ATP消耗(可能由于生成减少)和钠钾ATP酶抑制可能是其作用机制;3)氟是这种毒性的主要决定因素;4)肾小管损伤可在临床相关麻醉剂/无机氟浓度或接近该浓度时表现出来。IF麻醉后患者出现酶尿增加表明上述体外数据在特定患者中可能具有潜在临床意义。